PD-1 engagement leads to the activation of the inhibitory phosphatase SHP-2, thus resulting in the inhibition of TCR mediated function, increased T cell migration, and immune evasion within the tumor microenvironment (TME) (34). The gene discussed is PDCD1; the disease is neoplasm.